Skip to main navigation Skip to search Skip to main content

SIV envelope glycoprotein epitopes recognized by antibodies from infected or vaccinated rhesus macaques.

  • J. V. Torres
  • , D. E. Anderson
  • , A. Malley
  • , B. Banapour
  • , M. K. Axthelm
  • , E. Benjamini
  • , M. B. Gardner

Research output: Contribution to journalArticlepeer-review

Abstract

We analyzed SIV-specific monkey sera to localize B-cell epitopes of the envelope glycoprotein of SIV (gp130), using overlapping synthetic peptides representing the entire SIV gp130 protein and sera from experimentally infected monkeys and monkeys immunized with whole, inactivated SIV. A B-cell epitope which induces neutralizing antibody production and T-cell responses was characterized as well as a new B-cell epitope and a previously described neutralizing epitopes. Vaccinated monkey sera recognize the three epitopes differentially relative to unimmunized controls, and a correlation appears to exist between degree of cross-neutralization by infected monkey sera and degree of binding to these three regions.

Original languageEnglish (US)
Pages (from-to)129-137
Number of pages9
JournalJournal of medical primatology
Volume22
Issue number2-3
StatePublished - 1993
Externally publishedYes

Funding

FundersFunder number
National Institute of Health-National Cancer InstituteP01CA043447

    ASJC Scopus subject areas

    • Animal Science and Zoology
    • General Veterinary

    Fingerprint

    Dive into the research topics of 'SIV envelope glycoprotein epitopes recognized by antibodies from infected or vaccinated rhesus macaques.'. Together they form a unique fingerprint.

    Cite this